133 related articles for article (PubMed ID: 34009711)
1. Safety and effectiveness of metformin in patients with reduced renal function: A systematic review.
Orloff J; Min JY; Mushlin A; Flory J
Diabetes Obes Metab; 2021 Sep; 23(9):2035-2047. PubMed ID: 34009711
[TBL] [Abstract][Full Text] [Related]
2. Renal Complications after Percutaneous Coronary Interventions on Concurrent Metformin Therapy: A Systematic Review with Meta-Analysis.
Sakellariou XM; Kolettis TM; Nikas DN
Clin Med Res; 2023 Mar; 21(1):26-35. PubMed ID: 37130786
[No Abstract] [Full Text] [Related]
3. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
[TBL] [Abstract][Full Text] [Related]
4. Metformin: time to review its role and safety in chronic kidney disease.
Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials.
Clegg LE; Jing Y; Penland RC; Boulton DW; Hernandez AF; Holman RR; Vora J
Diabetes Obes Metab; 2021 May; 23(5):1101-1110. PubMed ID: 33394543
[TBL] [Abstract][Full Text] [Related]
6. Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis.
Kao TW; Lee KH; Chan WP; Fan KC; Liu CW; Huang YC
Eur Radiol; 2022 May; 32(5):3045-3055. PubMed ID: 34837099
[TBL] [Abstract][Full Text] [Related]
7. Increased vulnerability to COVID-19 in chronic kidney disease.
Carlson N; Nelveg-Kristensen KE; Freese Ballegaard E; Feldt-Rasmussen B; Hornum M; Kamper AL; Gislason G; Torp-Pedersen C
J Intern Med; 2021 Jul; 290(1):166-178. PubMed ID: 33452733
[TBL] [Abstract][Full Text] [Related]
8. Effect of estimated glomerular filtration rate (eGFR) on incidence of out-of-hospital cardiac arrests: A case-control study.
Lim HJ; Jeong J; Kim J; Ro YS; Shin SD
Resuscitation; 2019 Sep; 142():38-45. PubMed ID: 31299221
[TBL] [Abstract][Full Text] [Related]
9. Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease.
Marcum ZA; Forsberg CW; Moore KP; de Boer IH; Smith NL; Boyko EJ; Floyd JS
J Gen Intern Med; 2018 Feb; 33(2):155-165. PubMed ID: 29181788
[TBL] [Abstract][Full Text] [Related]
10. Appropriateness of metformin prescription for type 2 diabetes mellitus patients with chronic kidney disease (Stages 3-5).
Ramachandran M; Loi B; Mat Ariff N; Ng OC; Zahari Sham SY; Thambiah SC; Samsudin IN
Malays J Pathol; 2020 Apr; 42(1):71-76. PubMed ID: 32342933
[TBL] [Abstract][Full Text] [Related]
11. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Kalantar-Zadeh K; Kovesdy CP
Diabetes Care; 2016 Jul; 39(7):1281-6. PubMed ID: 27330129
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
13. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
[TBL] [Abstract][Full Text] [Related]
14. A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease.
Sorohan BM; Ismail G; Andronesi A; Micu G; Obrișcă B; Jurubiță R; Sinescu I; Baston C
BMC Nephrol; 2019 Jul; 20(1):276. PubMed ID: 31337351
[TBL] [Abstract][Full Text] [Related]
15. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
[TBL] [Abstract][Full Text] [Related]
16. The Associations of Plant Protein Intake With All-Cause Mortality in CKD.
Chen X; Wei G; Jalili T; Metos J; Giri A; Cho ME; Boucher R; Greene T; Beddhu S
Am J Kidney Dis; 2016 Mar; 67(3):423-30. PubMed ID: 26687923
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
Pastori D; Pignatelli P; Perticone F; Sciacqua A; Carnevale R; Farcomeni A; Basili S; Corazza GR; Davì G; Lip GYH; Violi F;
Int J Cardiol; 2016 Nov; 223():619-624. PubMed ID: 27565838
[TBL] [Abstract][Full Text] [Related]
18. Pain and Kidney Function Decline and Mortality: A Cohort Study of US Veterans.
Ravel V; Ahmadi SF; Streja E; Sosnov JA; Kovesdy CP; Kalantar-Zadeh K; Chen JLT
Am J Kidney Dis; 2016 Aug; 68(2):240-246. PubMed ID: 27108099
[TBL] [Abstract][Full Text] [Related]
19. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
[TBL] [Abstract][Full Text] [Related]
20. Effect of renal denervation on kidney function in patients with chronic kidney disease.
Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
